STAT+: Pharmalittle: We’re reading about PhRMA suing Trump, biotech frustration over tariffs, and more
PhRMA is suing the Trump administration, smaller biotech firms are frustrated over tariffs, and more of the latest pharma news.
Pharmaceutical manufacturers' trade group PhRMA has filed a lawsuit against the Trump administration, claiming that a Medicare drug price pilot program exceeds Medicare's authority. The pilot, known as GLOBE, ties Medicare Part B drug prices to those in peer countries. However, an exemption for most companies in the program means it likely won't have much impact.
Nevertheless, the industry is eager to prevent a precedent from being set. The administration is reportedly working on plans that would allow temporary sales of restricted peptides, enabling compounding pharmacies to distribute certain peptide products despite a lack of full safety testing.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
